A detailed history of New Edge Advisors, LLC transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, New Edge Advisors, LLC holds 1,254 shares of LH stock, worth $255,201. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,254
Previous 275 356.0%
Holding current value
$255,201
Previous $62,000 340.32%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$209.01 - $232.56 $204,620 - $227,676
979 Added 356.0%
1,254 $273,000
Q4 2023

Feb 13, 2024

BUY
$197.69 - $227.29 $16,803 - $19,319
85 Added 44.74%
275 $62,000
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $603 - $665
-3 Reduced 1.55%
190 $38,000
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $803,214 - $914,640
-3,790 Reduced 95.15%
193 $46,000
Q1 2023

May 12, 2023

BUY
$213.32 - $257.83 $754,086 - $911,429
3,535 Added 789.06%
3,983 $913,000
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $91,266 - $111,538
448 New
448 $105,000
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $350,757 - $402,543
-1,350 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$271.6 - $314.21 $152,639 - $176,586
562 Added 71.32%
1,350 $424,000
Q3 2021

Oct 29, 2021

BUY
$274.82 - $308.34 $216,558 - $242,971
788 New
788 $222,000
Q2 2021

Jul 22, 2021

SELL
$251.87 - $278.14 $529,934 - $585,206
-2,104 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$204.88 - $255.03 $431,067 - $536,583
2,104 New
2,104 $537,000
Q3 2017

Nov 13, 2017

SELL
$149.47 - $160.56 $43,047 - $46,241
-288 Closed
0 $0
Q2 2017

Aug 16, 2017

BUY
N/A
288
288 $0

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.2B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.